Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
Crossref DOI link: https://doi.org/10.1186/s13098-018-0327-4
Published Online: 2018-04-03
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moreira, Rodrigo Oliveira
Cobas, Roberta
Lopes Assis Coelho, Raquel C.
Text and Data Mining valid from 2018-04-03
Article History
Received: 20 December 2017
Accepted: 21 March 2018
First Online: 3 April 2018